Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
21.60
+0.13 (0.61%)
Feb 24, 2026, 3:00 PM CST
SHA:600285 Market Cap
SHA:600285 has a market cap or net worth of 12.09 billion as of February 23, 2026. Its market cap has increased by 1.23% in one year.
Market Cap
12.09B
Enterprise Value
11.29B
Revenue
3.78B
Ranking
n/a
PE Ratio
15.31
Stock Price
21.60
Market Cap Chart
Since January 2, 2001, SHA:600285's market cap has increased from 2.12B to 12.09B, an increase of 470.72%. That is a compound annual growth rate of 7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 12.09B | 3.67% |
| Dec 31, 2025 | 11.66B | -6.54% |
| Dec 31, 2024 | 12.48B | 29.34% |
| Dec 29, 2023 | 9.65B | 31.14% |
| Dec 30, 2022 | 7.36B | -17.51% |
| Dec 31, 2021 | 8.92B | 85.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Chipscreen Biosciences | 12.98B |
| Porton Pharma Solutions | 12.64B |
| Zhejiang Hisun Pharmaceutical | 11.99B |
| Beijing Foyou Pharma CO.,LTD | 11.87B |
| Zhejiang Hisoar Pharmaceutical | 11.84B |
| Mayinglong Pharmaceutical Group | 11.66B |
| Zhejiang CONBA Pharmaceutical | 11.23B |
| Shanghai Yizhong Pharmaceutical | 10.95B |